MY8700002A - Teichomycin a2 pure single factors 1 2 3 4 and 5 and method for their production - Google Patents

Teichomycin a2 pure single factors 1 2 3 4 and 5 and method for their production

Info

Publication number
MY8700002A
MY8700002A MY2/87A MY8700002A MY8700002A MY 8700002 A MY8700002 A MY 8700002A MY 2/87 A MY2/87 A MY 2/87A MY 8700002 A MY8700002 A MY 8700002A MY 8700002 A MY8700002 A MY 8700002A
Authority
MY
Malaysia
Prior art keywords
teichomycin
production
pure single
single factors
factors
Prior art date
Application number
MY2/87A
Other languages
English (en)
Inventor
Angelo Borghi
Rosa Palanzza
Carolina Coronelli
Giovanni Cassani
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of MY8700002A publication Critical patent/MY8700002A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MY2/87A 1982-06-08 1987-12-30 Teichomycin a2 pure single factors 1 2 3 4 and 5 and method for their production MY8700002A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (1)

Publication Number Publication Date
MY8700002A true MY8700002A (en) 1987-12-31

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
MY2/87A MY8700002A (en) 1982-06-08 1987-12-30 Teichomycin a2 pure single factors 1 2 3 4 and 5 and method for their production

Country Status (32)

Country Link
US (1) US4542018A (fr)
JP (5) JPS591423A (fr)
KR (1) KR900008246B1 (fr)
AU (1) AU560966B2 (fr)
BE (1) BE896993A (fr)
BG (1) BG60529B2 (fr)
CA (1) CA1208204A (fr)
CH (1) CH657139A5 (fr)
DE (1) DE3320342A1 (fr)
DK (1) DK159117C (fr)
ES (2) ES522941A0 (fr)
FI (1) FI73697C (fr)
FR (1) FR2528050B1 (fr)
GB (1) GB2121401B (fr)
GR (1) GR78267B (fr)
HK (1) HK55887A (fr)
HU (1) HU193538B (fr)
IE (1) IE55025B1 (fr)
IL (1) IL68819A0 (fr)
IT (1) IT1212085B (fr)
LU (1) LU84853A1 (fr)
MY (1) MY8700002A (fr)
NL (1) NL8301980A (fr)
NO (1) NO159104C (fr)
NZ (1) NZ204480A (fr)
PH (1) PH19533A (fr)
PT (1) PT76831B (fr)
SE (1) SE459094B (fr)
SG (1) SG70686G (fr)
SU (1) SU1318170A3 (fr)
UA (1) UA6025A1 (fr)
ZA (1) ZA833607B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992010516A1 (fr) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. Derives 38-decarboxy-38-hydroxymethyles d'antibiotiques a teicoplanine, et procede de preparation
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
CA2250578C (fr) 1996-04-23 2003-06-24 Versicor Inc. Procede chimique ameliore de preparation de derives d'amide de l'antibiotique a 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
MXPA05005338A (es) 2002-11-18 2005-12-14 Vicuron Pharm Inc Metodos para administrar dalbavancin para el tratamiento de infecciones bacterianas.
EP1806150A1 (fr) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Préparation contenant la teicoplanin
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
IT8321432A0 (it) 1983-06-02
JPH02291278A (ja) 1990-12-03
PT76831B (en) 1986-04-09
GR78267B (fr) 1984-09-26
SE459094B (sv) 1989-06-05
CH657139A5 (fr) 1986-08-15
FR2528050A1 (fr) 1983-12-09
DK245883A (da) 1983-12-09
JPH02288888A (ja) 1990-11-28
FI831660A0 (fi) 1983-05-12
FI73697C (fi) 1987-11-09
DE3320342A1 (de) 1983-12-08
SE8303211L (sv) 1983-12-09
IE831329L (en) 1983-12-08
PT76831A (en) 1983-07-01
BG60529B2 (bg) 1995-07-28
FI73697B (fi) 1987-07-31
ES8503689A1 (es) 1985-04-01
JPH02288887A (ja) 1990-11-28
UA6025A1 (uk) 1994-12-29
DK159117B (da) 1990-09-03
KR900008246B1 (ko) 1990-11-06
KR840005170A (ko) 1984-11-05
PH19533A (en) 1986-05-20
JPH0415238B2 (fr) 1992-03-17
JPH0415237B2 (fr) 1992-03-17
IL68819A0 (en) 1983-09-30
US4542018A (en) 1985-09-17
AU560966B2 (en) 1987-04-30
FI831660L (fi) 1983-12-09
DE3320342C2 (fr) 1991-07-11
NZ204480A (en) 1986-04-11
LU84853A1 (fr) 1984-03-07
HK55887A (en) 1987-08-07
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
JPH02291279A (ja) 1990-12-03
NL8301980A (nl) 1984-01-02
NO159104C (no) 1988-11-30
ES8506748A1 (es) 1985-08-16
CA1208204A (fr) 1986-07-22
ES536770A0 (es) 1985-08-16
JPH0517236B2 (fr) 1993-03-08
SG70686G (en) 1987-07-03
NO159104B (no) 1988-08-22
DK245883D0 (da) 1983-05-31
AU1496883A (en) 1983-12-15
GB2121401B (en) 1985-09-18
JPS591423A (ja) 1984-01-06
HU193538B (en) 1987-10-28
FR2528050B1 (fr) 1987-03-20
JPH0224278B2 (fr) 1990-05-29
GB8315003D0 (en) 1983-07-06
GB2121401A (en) 1983-12-21
NO831754L (no) 1983-12-09
ZA833607B (en) 1984-03-28
JPH0517237B2 (fr) 1993-03-08
SE8303211D0 (sv) 1983-06-07
SU1318170A3 (ru) 1987-06-15
ES522941A0 (es) 1985-04-01
DK159117C (da) 1991-02-11
BE896993A (fr) 1983-12-07

Similar Documents

Publication Publication Date Title
GB2121401B (en) Teichomycin a2 pure single factors1 2 3 4 and 5 and method for their production
DE3374317D1 (en) Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
GB2146607B (en) Micropcapsules and method for their production
ZA848273B (en) Armour-plate and process for its manufacture
EP0175495A3 (en) Superconducting apparatus
DE3370355D1 (en) Artificial firelogs and process for producting them
DE3364804D1 (en) Polyamide membrane and process for its production
DE3366836D1 (en) A47934 antibiotic and its production
GB8400059D0 (en) Cryogenic process
GB2117763B (en) A41030 antibiotics and their production
GB8504318D0 (en) Superconducting apparatus
DE3480197D1 (en) 5-alkylidene-2-halo-4-substituted-2-cyclopentenone and process for production thereof
DE3379506D1 (en) Process for producing peptide
DE3565741D1 (en) Method of manufacturing preferentially oriented (111)-tungsten
DE3371997D1 (en) Cl 1565 antibiotic compounds and their production
DE3573127D1 (en) Polyamide film and process for its production
DE3567382D1 (en) Process for separating so 2? and no x?
DE3366378D1 (en) Novel 2-beta-d-ribofuranosylselenazole-4-carboxamide compounds and methods for their production
GB2127821B (en) L-phenylalanine production
PL249429A1 (en) Process for preparing 6-demethyl-6-desoxy-6-methylene-5-oxytetracycyline and its 11 a-chloroderivatives
ZA831984B (en) A41030 antibiotics and their production
PH19351A (en) 4(5)-acetyl-2-methylimidazole process
ZA841477B (en) N-cyano-formamidines and processes for their production
ZA859033B (en) Expression vectors and method for their production
GB8516813D0 (en) Precipitation process